Kezar Life Sciences, Inc. (KZR)
NASDAQ·Healthcare·Biotechnology
$7.34
+0.69%
Mkt Cap $51.26M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 27, 2026 | $333.33K | — | — | -$1.31 | -$1.99 | -51.98% | — | — |
| Q4 2025 Nov 12, 2025 | — | — | — | -$1.81 | -$1.53 | +15.47% | — | — |
| Q3 2025 Aug 13, 2025 | — | — | — | -$2.15 | -$1.87 | +13.02% | — | — |
| Q2 2025 May 13, 2025 | — | — | — | -$2.56 | -$2.27 | +11.33% | — | — |
| Q1 2025 Mar 25, 2025 | — | — | — | -$2.71 | -$2.77 | -2.21% | — | — |
| Q4 2024 Nov 12, 2024 | $800.00K | — | — | -$3.03 | -$2.78 | +8.25% | — | — |
| Q3 2024 Aug 13, 2024 | $750.00K | — | — | -$3.20 | -$2.80 | +12.50% | — | — |
| Q2 2024 May 9, 2024 | $670.00K | — | — | -$3.40 | -$3.00 | +11.76% | — | — |
| Q1 2024 Mar 14, 2024 | — | -$5.43M | — | -$3.90 | -$3.50 | +10.26% | — | — |
| Q4 2023 Nov 13, 2023 | $166.67K | $7.00M | +4099.99% | -$3.60 | -$3.20 | +11.11% | — | — |
| Q3 2023 Aug 10, 2023 | — | — | — | -$3.30 | -$3.40 | -3.03% | — | — |
| Q2 2023 May 11, 2023 | — | — | — | -$2.80 | -$3.10 | -10.71% | — | — |
| Q1 2023 Mar 14, 2023 | — | — | — | -$2.40 | -$2.50 | -4.17% | — | — |
| Q4 2022 Nov 10, 2022 | — | — | — | -$2.60 | -$2.50 | +3.85% | — | — |
| Q3 2022 Aug 11, 2022 | — | — | — | -$2.70 | -$2.50 | +7.41% | — | — |
| Q2 2022 May 12, 2022 | — | — | — | -$2.90 | -$2.60 | +10.34% | — | — |
| Q1 2022 Mar 17, 2022 | — | — | — | -$2.90 | -$2.50 | +13.79% | — | — |
| Q4 2021 Nov 9, 2021 | — | — | — | -$2.60 | -$2.80 | -7.69% | — | — |
| Q3 2021 Aug 12, 2021 | — | — | — | -$2.60 | -$2.50 | +3.85% | — | — |
| Q2 2021 May 12, 2021 | — | — | — | -$2.40 | -$2.50 | -4.17% | — | — |